SCHEDULE: Disciplined Growth Investors Reports Myriad Genetics Stake

Disciplined Growth Investors, Inc. has reported a 0.8% passive ownership stake in Myriad Genetics Inc. common stock.

Summary

• Disciplined Growth Investors, Inc. (DGI) filed a Schedule 13G, indicating beneficial ownership of Myriad Genetics Inc. common stock.
• DGI holds 753,956 shares, representing 0.8% of Myriad Genetics' common stock.
• The filing states that the shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
• DGI, an investment adviser based in Minneapolis, MN, has sole voting and dispositive power over all 753,956 shares.

Sentiment

Score: 5

Explanation: The filing is a standard beneficial ownership report (Schedule 13G) indicating a passive investment. It contains no information that would inherently suggest a positive or negative sentiment regarding the issuer's performance or outlook.

Future Outlook

NA

Industry Context

This filing is a routine disclosure of a passive investment by an institutional investor in a publicly traded biotechnology company. It does not provide specific insights into Myriad Genetics' operational performance or strategic direction, but rather reflects an investment position by Disciplined Growth Investors, Inc. within the broader healthcare and diagnostics sector.

Stakeholder Impact

• Shareholders: Provides transparency regarding institutional ownership, confirming a passive stake by Disciplined Growth Investors, Inc.

Key Dates

Keywords

Myriad Genetics, Disciplined Growth Investors, MYGN, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, Biotechnology, Genetics